EU Pharma Industry Must Now Start Assessing Excipient Risks
This article was originally published in The Gold Sheet
An industry “how to” guide that aims to help pharmaceutical manufacturers comply with the EU’s new risk assessments for excipients says that implementation will be difficult. The new requirements took effect on March 21.
Register for our free email digests: